Warren Buffett: Rising Health Costs Are 'The Tapeworm' Harming U.S. Business

The Burden of Health Care Costs on American Business

If you've ever found yourself overwhelmed by medical bills, you're not alone. In fact, Warren Buffett once famously called health care "the tapeworm of American economic competitiveness," delivering a powerful and unflinching message about the real challenges facing the U.S. economy.

At the 2017 Berkshire Hathaway Annual Shareholders Meeting, Buffett made it clear that the true threat to American business isn’t taxes—it’s health care. He emphasized that while tax rates have decreased over time, health care costs have surged dramatically. According to Buffett, medical expenses have risen from 5% to 17% of GDP, making them a far greater burden on businesses than taxes.

Buffett's statement was backed by a simple but startling observation: “When American business talks about taxes strangling our competitiveness… they’re talking about something that… has gone down from four to two [percent of GDP], while medical costs… have gone from five to 17%.” This means that businesses are spending more on health care than on taxes, and this trend is only expected to grow.

Charlie Munger, Buffett’s longtime business partner, added his perspective with characteristic bluntness. He noted that even with socialized medicine in other countries, the U.S. still faces a significant challenge. “And that’s with socialized medicine,” he said, highlighting the inefficiencies and high costs within the American system.

Buffett didn’t shy away from the reality of the situation. He pointed out that the tax system isn’t crippling Berkshire’s competitiveness globally. Instead, the real issue is the rising cost of health care. While the U.S. spends 17% of its GDP on health care, other countries spend around 10% or 11%. This discrepancy, Buffett warned, is eroding the country’s competitive edge.

Munger expanded on the systemic issues he saw in the healthcare system. He criticized the overuse of medical treatments, such as excessive chemotherapy for patients who are already near death. “There's too much chemotherapy on people that are all but dead,” he said. He described the system as “crazy” and noted that the costs are spiraling out of control, putting American manufacturers at a disadvantage.

Together, Buffett and Munger painted a clear picture: the real problem isn’t inefficiencies in corporate taxes—it’s runaway medical spending, inefficiency, and misaligned incentives. Their comments underscored a broader issue that affects not just businesses but the entire economy.

Buffett also highlighted the long-term consequences of this trend. “If you talk about world competitiveness of American industry, it's the biggest single variable where we keep getting more and more out of whack with the rest of the world,” he said. For those who have followed economic trends, Buffett’s focus on health care feels refreshingly real. It’s a problem that affects everyone, from individuals managing their budgets to companies planning for the future.

In 2025, Buffett’s approach to this issue took a deliberate turn. Berkshire Hathaway invested $1.6 billion in UnitedHealth Group, the largest health insurer in the U.S. This move came at a challenging time for UnitedHealth, which was dealing with soaring care costs, government investigations, and fallout from a cyberattack. However, Buffett wasn’t betting on a quick fix—he was betting on endurance, recognizing that despite its flaws, the company still delivers returns.

The implications of Buffett’s warning remain relevant today. As health care costs continue to rise, they pose a significant challenge to the U.S. economy and its global competitiveness. Whether you're planning for retirement, managing your finances, or simply trying to understand the economic landscape, the impact of these costs is felt in both your health and your wallet.